Cargando…
NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to Adulthood
The NLRC4 inflammasome is part of the human immune innate system. Its activation leads to the cleavage of pro-inflammatory cytokines IL-1β and IL-18, promoting inflammation. NLRC4 gain-of-function (GOF) mutations have been associated with early-onset recurrent fever, recurrent macrophagic activation...
Autores principales: | Bardet, Juliette, Laverdure, Noémie, Fusaro, Mathieu, Picard, Capucine, Garnier, Lorna, Viel, Sébastien, Collardeau-Frachon, Sophie, Guillebon, Jean-Marie De, Durieu, Isabelle, Casari-Thery, Clémence, Mortamet, Guillaume, Laurent, Audrey, Belot, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509521/ https://www.ncbi.nlm.nih.gov/pubmed/34640385 http://dx.doi.org/10.3390/jcm10194369 |
Ejemplares similares
-
The Irrationality of GOF Avian Influenza Virus Research
por: Wain-Hobson, Simon
Publicado: (2014) -
Rescue of Pap-Mas in Systemic JIA Using Janus Kinase Inhibitors, Case Report and Systematic Review
por: Zekre, Franck, et al.
Publicado: (2023) -
GOF Mutant p53 in Cancers: A Therapeutic Challenge
por: Dolma, Lobsang, et al.
Publicado: (2022) -
Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
por: Schulz-Heddergott, Ramona, et al.
Publicado: (2018) -
Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
por: Wegehaupt, Oliver, et al.
Publicado: (2020)